Browse by Medical Category
Call to request an appointment or refer a patient:
Crohn’s disease and ulcerative colitis are lifelong diseases, and we treat patients of all ages. Our MassGeneral Hospital for Children pediatric specialists help parents address the special concerns of growth and physical and social development in their children and assist their adolescent patients in making a smooth transition to adult medical care at the appropriate time.
We offer a full range of conventional, innovative and investigational medical therapies and surgical procedures for Crohn’s disease and ulcerative colitis.
Our services include:
Whenever possible, multiple appointments are scheduled for the same visit.
Many patients are referred to the Crohn's and Colitis Center for a second opinion consultation from one of our world-class physicians. Patients benefit most from obtaining a second opinion because our physicians review each patient's previously assessed condition and discuss the full range of available treatments. Contact our access coordinator to schedule a consultation
We provide patients and referring physicians with an experienced access coordinator, a clinician who helps assess patient needs, coordinate appointments and begin the appropriate testing regimen. Calls will be returned within 24 hours. Contact the Crohn's and Colitis Center’s access coordinator
Our physicians are active in clinical trials and research studies related to new therapies for inflammatory bowel diseases, allowing us to bring our patients promising new treatments as quickly as possible.
Our patients can also choose to participate in an ongoing landmark study of Crohn’s disease and ulcerative colitis, known as PRISM. Through PRISM, we are investigating the genetic causes of IBD, with a goal of identifying markers that will predict the course of a patient’s disease. This information will benefit patients by leading to better diagnostic tests and new treatments.
Patients interested in participating in clinical trials canbrowse online for open trials.
The Crohn’s and Colitis Center’s specialists are advancing research on Crohn's and IBD treatment. Ramnik Xavier, MD, was the coauthor of a landmark publication that described 30 new genes that may contribute to Crohn’s disease. Richard Hodin,MD, director of the Laboratory of Gastrointestinal Epithelial Biology, is investigating a promising new therapy for IBD called intestinal alkaline phosphatase.
We are part of The Center for the Study of IBD, a multimillion dollar National Institutes of Health-funded program devoted to finding new treatments for inflammatory bowel diseases. We are also performing extensive research on the role of bacteria in the digestive track and the genetic factors that cause Crohn’s and colitis.
We host an internationally recognized annual symposium on inflammatory bowel disease. The symposium draws experts from around the world who share their expertise and explore the latest advances in the causes of Crohn’s disease and ulcerative colitis.
Patients interested in participating in clinical trials can browse online for open trials.
Celiac disease is a digestive disease that damages the small intestine because of a sensitivity to gluten, which is found in wheat, rye, barley, and oats. This hereditary disorder interferes with the absorption of nutrients from food.
Crohn's disease is an inflammatory bowel disease that is a chronic condition that may recur at various times over a lifetime.
Ulcerative colitis is an inflammatory bowel disease in which the inner lining of the large intestine (colon or bowel) and rectum become inflamed.
Crohn's and Colitis Center
To begin the appointment process, contact the Crohn's and Colitis Center access coordinator at 617-724-6005 or request an appointment online.
Back to Top